Certara的Q2 EPS为0.07美元,损失估计数为0.03美元,收入为2.7M美元;股票跌至12.51美元。 Certara's Q2 EPS of $0.07 missed estimate by $0.03 and revenue by $2.7M; shares dropped to $12.51.

Certara(NASDAQ:CERT)报告Q2 EPS为0.7美元,缺0.10美元估计数为0.03美元,收入为93.31M美元相对于96.01M美元共识。 Certara (NASDAQ: CERT) reported Q2 EPS of $0.07, missing $0.10 estimate by $0.03, and revenue of $93.31M vs $96.01M consensus. Yoy收入增长3.2%,FY24指导为0.41至0.46 EPS。 YoY revenue grew 3.2%, and FY24 guidance is $0.41-$0.46 EPS. 尽管如此,股票下跌,达到12.51美元。 Despite this, shares dropped, reaching $12.51. Certara提供软件产品和技术辅助服务,用于药物发现、研究等生物模拟。 Certara offers software products & tech-enabled services for biosimulation in drug discovery, research, and more.